Abstract: Mounting evidence suggests that weight management and physical activity (PA) improve overall health and well being, and reduce the risk of morbidity and mortality among cancer survivors. Although many opportunities exist to include weight management and PA in routine cancer care, several barriers remain. This review summarizes key topics addressed in a recent National Academies of Science, Engineering, and Medicine workshop entitled, "Incorporating Weight Management and Physical Activity Throughout the Cancer Care Continuum." Discussions related to body weight and PA among cancer survivors included: 1) current knowledge and gaps related to health outcomes; 2) effective intervention approaches; 3) addressing the needs of diverse populations of cancer survivors; 4) opportunities and challenges of workforce, care coordination, and technologies for program implementation; 5) models of care; and 6) program coverage. While more discoveries are still needed for the provision of optimal weight-management and PA programs for cancer survivors, obesity and inactivity currently jeopardize their overall health and quality of life. Actionable future directions are presented for research; practice and policy changes required to assure the availability of effective, affordable, and feasible weight management; and PA services for all cancer survivors as a part of their routine cancer care. CA Cancer J Clin 2017;000:000-000.
Introduction
With growing evidence of the association between obesity, excess weight, and cancer, the National Cancer Policy Forum (NCPF) of the National Academies of Sciences, Engineering, and Medicine hosted a workshop in 2011 on the "Role of Obesity in Cancer Survival and Recurrence." That workshop examined epidemiologic evidence, biologic mechanisms, preclinical studies, and a limited number of randomized controlled trials (RCTs) of interventions that promoted weight loss via caloric restriction or increased physical activity (PA) in patients with cancer. 1 Two scientific papers emanated from this endeavor-one that was more mechanistic in nature, 2 and the other focused on translational research for patient care. 3 Both emphasized gaps in knowledge.
1 quality of life (QOL) and fatigue. Finally, it identifies evidence gaps addressed by ongoing and recent trials, gaps that remain, and the opportunities to fill these gaps.
Overview of Obesity and Cancer Outcomes
Excess weight gain, overweight, and obesity are associated with an increased risk of many cancers; recently, the International Agency for Research on Cancer reported that there is sufficient evidence to conclude that avoidance of excess body fat is associated with a lower risk for cancers of the endometrium, esophagus (adenocarcinoma), gastric cardia, kidney (renal cell), multiple myeloma, meningioma, liver, pancreas, colorectum, gallbladder, breast (postmenopausal), ovary, and thyroid. 8 There also is growing observational evidence that obesity is associated with poorer cancer outcomes among individuals with cancer. The largest body of evidence relates to breast cancer. A meta-analysis of 82 studies involving 213,075 women with breast cancer found a 41% relative increase in all-cause mortality for women with obesity versus those of normal weight (relative increases were 75% in premenopausal women and 34% in postmenopausal women). 9 That study also reported increased all-cause mortality for overweight women, albeit the relative increases were smaller. Another meta-analysis found that the risk of mortality associated with overweight and obesity was similar for patients with estrogen receptor (ER)-positive and ERnegative breast cancer, although some (but not all) subsequent individual studies have suggested that the risk may be present only in women with ER-positive disease. 10 Among breast cancer survivors treated with anthracyclines, obesity also is associated with greater cardiotoxicity. 11 Similarly, adverse associations of obesity with survival are reported for endometrial, prostatic, pancreatic, colorectal, and ovarian cancer as well as some hematologic malignancies. 3, 4 In contrast, overweight and obesity are associated with somewhat better outcomes in lung, esophageal, and kidney cancercancers in which the morbidity of cachexia and advanced stage at diagnosis are more common. 12 The association of excess weight gain, overweight, and obesity with cancer is biologically complex. Increased adiposity results in changes in adipose tissue, including death of adipocytes, leading to infiltration of inflammatory cells, as well as secretion of cytokines and other factors that stimulate cancer cell growth, invasion, angiogenesis, and metastasis. 13 Increased adiposity also is associated with changes in systemic physiology, including insulin resistance, dysglycemia, altered adipokines, and increased inflammation; together, these changes enhance signaling through key growth pathways (eg, PI3K, RAS, JAK-STAT) and alter cellular metabolism. 2, 14 These obesity-associated effects at the tissue and physiologic levels invoke changes in many of the hallmarks of cancer, 15 including sustained proliferative signaling, activated invasion and metastasis, induced angiogenesis, and resistance to cell death. 2 Overweight and obesity also enable deregulation of cellular energetics and tumor-promoting inflammation. 2, 15 While observational data obtained from a multitude of studies, coupled with this strong biologic rationale, provide strong support for an association of obesity with poor cancer outcomes, there is insufficient evidence to conclude that this association is causal. Studies examining weight-related changes in the transcriptome of breast cancers indicate that cancers developing in women with obesity are biologically different from those in women of normal weight in terms of altered gene regulation and expression. 16 At this time, it is unclear whether reversal of obesity will lead to reversal of these differences or lead to improved cancer outcomes. RCTs of weight loss or pharmacologic interventions that reverse obesity-associated changes related to overweight and obesity are needed.
Overview of the Evidence on Cancer Outcomes Related to PA
Evidence linking increased PA to improved cancer outcomes is preliminary but promising. A recent systematic review and pooled analysis of 26 observational studies found that cancer survivors who engaged in higher levels of PA (>18 metabolic equivalent hours per week) had a 37% lower risk of dying from cancer, compared with those who engaged in lower levels of PA (<1.5 metabolic equivalent hours per week; hazard ratio [HR] , 0.63; 95% confidence interval [95% CI], 0.54-0.73). 17 This risk reduction is remarkably consistent across breast, colorectal, and prostate cancer survivors. There also is growing evidence that the association between PA and cancer mortality varies by specific molecular or genetic markers, suggesting a possible precision medicine approach to exercise oncology (eg, a strong inverse association between PA and colon cancer mortality is noted for survivors whose tumors express p27 [HR, 0.32; 95% CI, 0.12-0.85]). In addition, the link between PA and cancer outcomes has strong biologic plausibility related to sex hormones, cell growth regulators, DNA damage repair, inflammatory markers, immune function, and antioxidant pathways. 18 RCTs are needed to establish the causal effects of PA on cancer outcomes. The Colon Health and Life-Long Exercise Change (CHALLENGE) Trial is the first phase 3 trial examining the effects of a 3-year structured PA program on disease-free survival in patients with stage II and III colon cancer who have recently completed chemotherapy. 19 To date, the trial has demonstrated feasibility in accrual 20 and PA behavior change 21 ; it has randomized over 590 of the planned 962 patients. The Intense Exercise for Survival (INTERVAL) Trial is another phase 3 trial examining the effects of a 2-year structured PA program on overall survival CA CANCER J CLIN 2017;00:00-00 VOLUME 00 _ NUMBER 00 _ MONTH 2017 in 866 men with metastatic, castrate-resistant prostate cancer. 22 These trials, and others like them, will provide the first definitive evidence on the role of PA in improving cancer outcomes.
Influence of Weight Management and PA on QOL Outcomes
Although obtaining evidence of the impact of weight management and PA on cancer progression and mortality is critical, many cancer survivors experience significant comorbidities, or cancer-related and treatment-related physical and psychosocial problems that compromise their QOL. 23 Healthy eating, regular PA, and maintaining a healthy weight have been recommended for cancer survivors to prevent, mitigate, and manage these downstream sequelae.
24,25
Weight gain with concomitant loss of muscle (ie, sarcopenic obesity) and bone are common after chemotherapy and hormone therapy, placing cancer survivors at risk for comorbidities, such as cardiovascular disease (CVD), diabetes, second primary cancers, osteoporosis, and functional decline. 25, 26 Research indicates that diet-induced and exercise-induced weight management interventions can produce clinically meaningful weight loss in cancer survivors within 6 months, resulting in improved blood lipids and metabolic health and reduced inflammation. 27-31 Also, several studies have reported positive effects of targeted PA on bone health, [32] [33] [34] which is important because osteoporosis and the risk of subsequent fractures is increased by 15% to 20% among cancer survivors who receive hormone treatment for breast or prostate cancer. 35 Growing numbers of studies have examined the effects of PA on CVD in cancer survivors, with a meta-analysis indicating that PA improves cardiorespiratory fitness-a powerful predictor of mortality. 36 cer, provides some of the only RCT data and suggests that a mean nonprescribed weight loss of 6 pounds, resulting from a fat-restricted diet, was associated with a significant decrease in subsequent breast cancer events (local, regional, and distant recurrence; ipsilateral breast recurrence after lumpectomy; and contralateral breast cancer) compared with a control arm (ie, 9.8% vs 12.4%; P 5 .034), a finding driven by women diagnosed with ER-negative disease. 44 However, because the dietary fat intervention also led to weigh loss in that study, 45 it is impossible to disentangle whether the low-fat diet or the weight loss was most responsible for cancer control. Other questions remain about the biologic pathways that underlie the relationship between weight management and PA and malignancy; the relative contribution of body weight, diet, and/or PA to cancer outcomes; the optimal timing, dose, and duration of weight management and PA interventions; and the best ways of implementing weight management and PA interventions in diverse cancer populations. 44 Moreover, the science regarding cancer outcomes and sedentary time also needs to be further developed, as well as the evaluation of potential interventions to limit sedentary time. Several ongoing trials aim to address these evidence gaps (see Table 2 ). 19, [46] [47] [48] Each of the ongoing studies examines the impact of weight loss or increased PA, either alone or in combination with improvements in diet quality, on cancer recurrence, cancer-related mortality, or overall survival in individuals diagnosed with a single malignancy. None of the studies compares the effects of different weight management or PA interventions or of different doses or durations of intervention. one-half of the trials enroll breast cancer survivors, and the majority focus on those with no evidence of active disease. Although these trials will provide critical information regarding the role of weight management and PA in the management of cancer survivors, several gaps will remain. Given that each trial focuses on the effect of a particular weight management or PA intervention in a specific cancer survivor population, it will be difficult to generalize the information gained from these studies across all cancer survivors or to other types of interventions. Moreover, from a feasibility and economic standpoint, it is unlikely that there ever will be trials conducted to evaluate the effect of each type of weight management and PA intervention on every malignancy. So, how do we bridge these evidence gaps and ensure that all cancer survivors have access to weight management and PA interventions that could reduce the risk of Weight Management and Physical Activity Throughout the Cancer Care Continuum 
Summary
Ongoing trials will provide vital information on weight management and PA interventions with and without improvements in diet quality on cancer recurrence and survival, but several important knowledge gaps will remain. Biomarker analyses offer the potential to extend the knowledge gained from these trials to other patient populations and could ultimately determine the components of optimal interventions and how they are best applied in a personalized medicine approach to improve cancer outcomes. While more research is needed to elucidate the impact of weight management and PA on cancer-specific outcomes, it is important to note that ASCO now recommends discussion about weight management, including dietary and PA changes, among oncology providers and their patients. 4 This recommendation stems from solid evidence that diet, PA, and reduced adiposity play critical roles in preventing CVD and diabetes and exert a positive influence on QOL, physical function, and fatigue. Aerobic PA of sufficient volume and intensity ("exercise") to improve cardiorespiratory fitness, which is a potent biomarker of morbidity and all-cause mortality, needs to be frontline care in both healthy and cancer survivor populations.
67-69 Consistent aerobic exercise can delay the onset of disability by more than 10 years and markedly increases survival among older adults with projected lifespans of at least 20 years (the length of survivorship that burgeoning numbers of cancer survivors are now achieving). 7, 70 Among cancer survivors, data indicate that high versus low cardiorespiratory fitness reduces the risk of mortality by 45%.
71
Likewise, resistance PA of sufficient volume and intensity ("exercise") to increase neuromuscular fitness (ie, LBM, strength, power, fatigue resistance) is key to frontline care. Low LBM is a major predictor of all-cause mortality and physical disability. 72 Resistance exercise has repeatedly been shown to improve neuromuscular fitness and skeletal health and to reduce the risk of disability. 73, 74 Although the molecular underpinnings of PA-driven health benefits have not been fully elucidated, significant progress has been made, 75 and more information will be gleaned via the National Institutes of Health (NIH)-funded Molecular Transducers of Physical Activity Consortium (MoTrPAC), which is charged with mapping molecular responses to aerobic and resistance exercise to more fully understand the cellular and molecular signals that drive potential health benefits. This vital step will enable a precision medicine approach and the individualization of exercise prescriptions.
63,75

Interventions for Weight Management in Cancer Survivors
Data indicate that weight loss can be promoted among cancer survivors who are overweight or have obesity.
31,76
Sentinel studies of weight management are summarized in 
Interventions to Improve PA in Cancer Survivors
Various PA interventions have been evaluated in cancer survivors, although the body of evidence is primarily limited to short-term studies of 12 to 16 weeks' duration among breast cancer survivors. Approaches are typically clinic-based or home-based (eg, telephone counseling, print, Web, social media). In general, stronger outcomes are associated with clinic-based programs, whereas greater reach and reduced participant burden are associated with home-based interventions. 96 However, this generalization is affected by the motivation of the cancer survivor; as shown by data from the LEAN (Lifestyle, Exercise, and Nutrition) study, which found no differences in effects between the modes of delivery. 30 On-site, clinic-based programs are generally supervised by exercise professionals and tend to have higher exercise intensity dose and closer supervision and monitoring. Home-based programs tend to promote , intensity, frequency, and duration) to achieve which outcomes and for whom, 101 as well as when in the course of the cancer continuum programs should be offered. Identifying the minimal PA dose for QOL improvements, weight and symptom management, and survival will assist in developing pragmatic programs that target outcomes relevant to patients' needs (eg, management of fatigue and pain). Looking ahead, improvements in the recovery and functioning of the growing numbers of cancer survivors may emerge from use of behavior change theories to inform intervention development, use of information technology and mHealth technologies to widen the reach of programs, plans for maintenance of behavior change, and assessment of program costs. There are numerous missed opportunities for health care professionals in oncology and primary care settings to promote PA for their patients at various points across the cancer care continuum. Addressing the barriers faced by providers 96, 102 and providing guidelines to help triage patients to effective programs (eg, clinic-based, community-based, or home-based) are sorely needed.
Summary
Research in the general population has demonstrated the benefits of weight management and PA for the prevention and management of diabetes and other chronic diseases, reducing disability, and delaying mortality. As research on weight management, PA, and cancer survivorship moves beyond small, early clinical trials that evaluate the effects of these interventions on biomarkers and QOL, larger trials are needed to test the effects of the interventions on disease-free and overall survival, especially in disease sites other than breast cancer, and to include adequate representation of population subgroups defined by comorbidity/ functional status, race, ethnicity, or age. To ensure that clinical trials are appropriately designed to provide more definitive answers, the NIH has recently established new guidance related to funding applications submitted to the NIH for all clinical trials. 103 Specific institutes, such as the National Cancer Institute, have used expert working groups to discuss trial design issues within their clinical trial networks, including those related to behavioral interventions. Within the NIH Obesity Research Task Force, the National Heart Lung and Blood Institute is leading an effort to identify additional factors that may predict successful response to weight management interventions. The Accumulating Data to Optimally Predict obesity Treatment (ADOPT) Core Measures Project was developed in response to the well documented individual variability in response. 104 ADOPT is designed to provide investigators with tools to generate an evidence base that may advance understanding of the behavioral, psychosocial, environmental, and biologic sources of this variability. Working with an expert panel of investigators, a trans-NIH group identified an initial core set of high-priority measures that, when consistently used in trials, may facilitate the prediction of treatment response. The NIH is now exploring approaches for increasing the use of consistent measures across trials so that data can be pooled and used to identify reliable predictors, mediators, and moderators of response. This accumulation of efficacy evidence will likely spur the translation of effective interventions into clinical practice, although research in implementation science also is needed to best adapt interventions to enhance their reach, scope, and uptake among populations and settings that may not be representative of clinical trials.
Addressing the Weight Management and PA Needs of Diverse Populations of Cancer Survivors
Low-income, minority populations, particularly African Americans and Hispanics, as well as those who are older and live in rural areas bear a disproportionate burden of cancer. 7, [105] [106] [107] Moreover, these populations also are more likely to be overweight or obese, physically inactive, and to manifest health conditions that are affected by these factors, such as metabolic syndrome-all of which are associated with greater comorbidity and reduced survival (overall and cancer-specific). This section addresses weight management and PA among diverse populations.
Meeting the Needs of Diverse Survivors in Terms of Race/Ethnicity, Culture, and Language
Among cancer survivors, prevalence of overweight and obesity is high, especially among non-Hispanic blacks and Hispanics compared with non-Hispanic whites. 108 Concordantly, cancer survivors who are members of minority groups have lower adherence to diet and PA guidelines and are more likely to report poorer health status compared with nonminority cancer survivors or racial/ethnic minorities without cancer. [109] [110] [111] [112] [113] [114] [115] Thus, there is a critical need to develop and examine weight management and PA interventions among cancer survivors of racial/ethnic minority status to enhance outcomes and reduce disparities. Consideration of patients' environmental, cultural, and survivorship context is critical to the success of these efforts. 116 Racial and ethnic minority survivors are more likely to live in areas characterized by high segregation, traffic density, and crime and by low neighborhood socioeconomic status and access to fullservice supermarkets and PA resources. [117] [118] [119] Despite this, most communities, including lower socioeconomic neighborhoods, also have some assets, such as farmers' markets, public recreation systems, and community gardens that support PA, healthy eating, and reduction of chronic disease. [120] [121] [122] Partnering with community organizations to bring interventions to under-resourced neighborhoods provides opportunities to build social capital, reach more cancer survivors, and increase potential for sustainability.
123
Consideration of cultural norms is important. Culture varies among and within racial and ethnic groups, influencing beliefs, behaviors, and patient-provider interactions related to cancer, obesity, and lifestyle. The conceptual framework of Kreuter et al 124 can inform cultural tailoring and structure formative work, thereby enhancing the relevance of an intervention approach and content to a particular population (see Table 4 ). 124 Similarly, because cancer survivors report greater interest in programs that acknowledge their cancer journey and concerns, it is important for programs to address these issues. 125 In addition to context, biopsychosocial approaches to research are needed to understand and address the multilevel factors (from cells to society) that affect weight status and behavior and influence cancer control, overall health, and QOL. 107 To date, weight management and PA interventions among racial/ethnic minority cancer survivors have established feasibility and safety and report positive, albeit modest, results, including weight loss, behavioral changes, improved QOL and biomarker status, and decreased cancer-related anxiety. 84, 87, 88, 90, [126] [127] [128] [129] [130] [131] [132] [133] Limitations of many studies include quasi-experimental designs, small sample sizes, a focus on behavioral outcomes, and sole inclusion of breast cancer survivors. Only 3 studies assessed biomarkers, 87, 90, 128 and only one targeted a cancer other than breast 134 -none included men. Recent efforts address some of these limitations. 135, 136 Important steps to advance the science of obesity and lifestyle interventions in diverse populations include using more rigorous methodologies, addressing multilevel mediators and moderators of change, examining biologic mechanisms related to energy balance and cancer, and addressing more diverse cancer survivor populations.
Meeting the Needs of Cancer Survivors Across the Lifespan
Currently, 62% of cancer survivors are age 65 years and older-a subpopulation that will continue to grow with the aging of the population along with earlier diagnosis and improvements in treatment. 137 However, cancer also affects the young. In the United States, there are almost 400,000 childhood cancer survivors and 70,000 adolescent and young adult cancer survivors, many of whom could have long lives ahead of them. 137 Lifestyle interventions are sorely needed by survivor populations of all age groups, because suboptimal diets and insufficient PA are noted in 40% to 70% and 54% to 84% of younger cancer survivors, respectively, [138] [139] [140] [141] and in 52% to 85% and In addition, up to 71% of older cancer survivors are overweight or have obesity, and these conditions also are prevalent in children, adolescents, and young adults diagnosed with acute lymphocytic leukemia and some forms of brain cancer. 140, 142 A unifying theme shared by both young and old cancer survivors is that of the long-term and late effects of cancer and their treatment, many of which are influenced by nutritional status and PA, 145 such as increased risk of CVD, second cancers, osteoporosis, metabolic syndrome, fatigue, cognitive changes, and sarcopenia. Underlying many of these conditions is the process of accelerated aging and frailty among cancer survivors, which occurs across all age groups. Frailty, or an "insufficient reserve to recover," is generally preceded by diminished function, 146 both of which increase with age. However, illnesses and injury, as occur with cancer and its treatment, accelerate this course, especially among females. 145 Other factors, such as a poor diet, physical inactivity, and obesity, further exacerbate functional decline and the onset of frailty. 147 Despite the potential benefits of weight management to forestall frailty and common comorbidities, caution is needed in pursuing weight loss. Until more data are available specifically on cancer survivors, the AHA/ACC/TOS and National Heart Lung and Blood Institute guidelines can inform best practices. 54, 150 Among these guidelines is the recommendation for a rate of weight loss of 1 to 2 pounds per week. Because sarcopenia is a common condition that accompanies cancer and its treatment and one that accelerates aging, slower rates of weight loss that minimize LBM loss, concurrent with strength training, are recommended. 151 For older adults, weight loss guidelines suggest an energy deficit of 500 to 750 kcal daily to promote a weight loss of up to 1.5 pounds per week 152 ; for childhood and adolescent cancer survivors, energy deficits of up to 250 kcal per day to invoke a maximum weight loss of 0.5 pounds per week are recommended. 153 Also, behavioral approaches, such as substituting higher energy with lower energy density foods, avoiding distracted eating, and adopting slower rates of eating, are commonly used tactics to help prevent weight gain in adults and allow children to "grow into their weight." Regular PA is important for cancer survivors of any age to achieve optimal health. Thus the avoidance of inactivity is key, and adaptations need to be made to accommodate limitations or comorbidities because of cancer or its treatment. 24 ; although, for children, this recommendation is made within the context of a sports curriculum and with adequate supervision. 155 The benefits of low-intensity PA have recently been reported as well; however, to date, there are no guidelines in this area. 156 The means by which weight management and PA are promoted in younger versus older cancer survivors differs. [157] [158] [159] [160] [161] For example, children have preferences for game-based or playbased interventions, whereas older adults favor holistic interventions (eg, gardening, dancing) that have personal meaning and/or involve others. Because of prevalent functional and sensory deficits among the young and the old, it is critical that interventions use large font (and screen size), volume control, module brevity, pretraining, and support for new technologies, especially those that allow for homebased delivery. 162 Exemplar interventions are featured in Table 3 . 91, 93, 163 In addition, given the key role that caregivers play in the lives of children and older adults, an unexplored area with potential is the use of dyadic approaches.
Meeting the Needs of Rural Cancer Survivors
Rural cancer survivors (ie, those residing in nonmetropolitan counties, as defined by the Office of Management and Budget) 164 have higher cancer mortality rates compared with urban residents across all regions of the United States. Moreover, death rates from cancer have declined at a slower rate in rural compared with urban counties. 165 Among cancer survivors, those from rural areas report poorer health status, more psychological distress, 166 higher rates of depression and anxiety, 167 and greater knowledge gaps related to their cancer and its treatment effects. Rural cancer survivors also report high levels of unmet support needs. 168 These disparities are compounded by higher rates of comorbidities, obesity, and physical inactivity among rural compared with urban residents. [169] [170] [171] [172] Rural cancer disparities affect a significant proportion of our population. Nearly 20% of Americans, 173 and an estimated 21% of cancer survivors, reside in a rural area, representing roughly 2.8 million survivors. 166 Rural residents are a diverse group. Nationwide, 78% of rural residents are non-Hispanic white; however, higher proportions of African Americans and Hispanics reside in the south and southwest, respectively. Despite their diversity, rural residents often share common cultural elements, such as conventional attitudes, self-reliance, and orientation toward work, family, and religion. 174 Rural residents of all racial/ethnic groups are also older, poorer, and have less education than their urban counterparts. 161 These demographic differences, in addition to the contextual, cultural, and access factors stemming from place of residence, contribute to rural cancer disparities. 175 All of these factors need to be considered when designing lifestyle interventions for rural cancer survivors. Effective, remote-based interventions are essential to maximize reach into rural communities because of challenges with access to health care services (including specialized services for weight management and PA), travel time, and financial barriers. With approximately 3% of medical oncologists 176 and very few specialized psycho-oncology providers practicing in rural communities, there is a gap in services for supportive care and lifestyle interventions. 177 Travel time and transportation costs pose barriers for inperson lifestyle interventions, particularly in frontier regions. Survey results among rural breast cancer survivors in Kansas and Illinois found that the vast majority did not met PA guidelines 178 but rated PA and weight management programs as a top need. 179 To date, there is only one published trial of a full-scale lifestyle intervention done exclusively in a rural setting. Befort et al 180 enrolled 210 breast cancer survivors into a 6-month telephone-based intervention delivered by a weekly conference calls. The study demonstrated feasibility and achieved a 12.9% weight loss-with a 10.6% net loss maintained at 18 months-through continued, but scaled back, conference calls. Lessons learned from that study are needs for: 1) direct patient recruitment through cancer registries (direct mailing yielded 84% of participants, whereas physician referrals yielded only 4%); 2) clinical integration (because of high levels of comorbid conditions); and 3) group support among rural women. 181 While the intervention was exclusively home based, many participants arranged to meet in person with one another; therefore, some face-to-face contact may enhance intervention efficacy for some and needs to be considered in future programming. Additional research also is needed to better understand environmental determinants of diet and PA in rural areas and contextual factors influencing successful implementation across various health care and community settings.
Summary
Overall, there are limited data available on the effectiveness of weight management and PA interventions for diverse populations, although feasibility and safety have been established. In each unique population, various factors must be addressed to ensure that weight management, PA, and behavioral modification elements address physiologic needs and health issues (eg, promoting slower weight loss among pediatric and geriatric cancer survivors who are at greater risk for stunting and sarcopenia, respectively), individual preferences (eg, home-based delivery to overcome travel barriers), and community-based resources (eg, partnering with community-based organizations for program implementation). Given the higher prevalence of overweight and obesity and suboptimal lifestyle practices among certain subpopulations of cancer survivors (eg, racial/ethnic minorities, those residing in rural areas, pediatric and older cancer survivors) there is a need to target interventions to these diverse populations that are currently more likely to have poorer outcomes and shorter years of survival.
Opportunities and Challenges for the Workforce, Care Coordination, and Technologies to Support Weight Management and PA in Cancer Survivors
Several factors currently limit the ability to deliver weight management and PA programs to all cancer survivors who need them. These barriers exist at multiple levels. Barriers at the level of the cancer survivor and family have been covered in the sections above and include factors such as high costs, lack of geographic access to these programs, or lack of knowledge or motivation of how to change health behaviors. These may be compounded by barriers at the level of the clinician, such as lack of clinician comfort with discussing weight with patients or lack of knowledge of which intervention to refer or prescribe, as well as competing demands for time in the clinical encounter. Finally, barriers at the level of the health care system and the environment present further challenges; for example, a lack of prioritization of PA, weight management, or disease prevention in general; a lack of insurance coverage for lifestyle change programs; or the obesogenic environment. These challenges and current strategies to overcome them are described below.
Weight Management and PA: Clinical Care Opportunities and Challenges
A health care professional's recommendation to exercise significantly improves PA engagement, 96 ,182 yet many providers do not counsel patients who might benefit on the need for PA or weight management. Research shows that providers are more likely to encourage a change in health behavior if they have established a positive patient-physician relationship, have available referral resources to facilitate health behavior change, and believe that health behavior engagement will benefit cancer outcomes or overall health and well being. 183 Several individual and systems barriers need to be overcome to promote PA and weight management in the delivery of survivorship care. Competing time demands during oncology visits dictate that oncology care providers help patients make difficult choices about therapy, monitor side effects, promote adherence to oral medications, administer screening evaluations, and help patients cope with the psychological effects of cancer diagnosis and treatment, presenting significant obstacles to discussions of PA and weight management. [183] [184] [185] [186] Moreover, in the current age of electronic medical records, health care professionals in general spend only one-half of their scheduled clinic visit time talking with the patient and over one-third of their time on documentation. 187 Furthermore, most health care professionals do not receive adequate training in how to operationalize health behavior recommendations at the level of an individual patient, 185 so a generalized lack of expertise or competency in knowing what and how to recommend changes is a major barrier. Providers also need resources for appropriate services (eg, dietitians, exercise specialists, or programs) 183, 188, 189 ; but a lack of supportive infrastructure, including lack of access to appropriate referrals or effective strategies as well as limited insurance coverage, can inhibit provider recommendations. 184, 185 Care providers also may be skeptical that a cancer survivor can change behavior or may worry that engaging in weight management or PA during or after treatment may be risky to the survivor's overall health. 183 Finally, a lack of knowledge about the benefits of weight management and PA can result in a lack of motivation to focus on this topic. 183 Fortunately, there are several resources available for cancer survivors and health care professionals to help promote weight management and PA (see Table 5 ).
Overcoming Workforce Issues and Establishing Common Competencies
The contribution of excess weight and physical inactivity to cancer and overall health outcomes emphasizes the need for health professional education and adoption of appropriate competencies. The lack of a standard of care for overweight and obesity and its associated lifestyle factors, the mismatch of disease burden with care provider capacity, and the lack of integrated clinical and community services constitute major barriers to effective care. Behavior change is the cornerstone of therapy. For the care of pediatric patients with obesity, the USPSTF recommends moderate-to-highintensity behavioral interventions, including nutrition, PA, and behavioral counseling for a minimum of 26 contact hours. 190 For adults with obesity, the USPSTF recommends obesity behavioral interventions that include selfmonitoring and from 12 to 26 visits over the course of a year. 51 However, few providers have been trained in the delivery of behavior change therapies; and, currently, few major insurance plans provide reimbursement for the duration of care recommended by the USPSTF. A second gap is the lack of understanding of the most fundamental elements of obesity care. For example, less than 50% of internists, family practitioners, obstetricians/ gynecologists, and nurse practitioners surveyed knew the CA CANCER J CLIN 2017;00:00-00 VOLUME 00 _ NUMBER 00 _ MONTH 2017 recommended level of PA for adults, and even fewer knew the USPSTF guidelines for treatment of obesity. Similar surveys have not been administered to oncology care providers; however, their knowledge in these areas is not likely to be better. To address these gaps, 24 organizations involved in the care of obesity convened to develop common competencies for the prevention and treatment of obesity. 191 This effort, funded by the Robert Wood Johnson Foundation, led to the development of 10 major competencies, which are shown in an abbreviated form in Table 6 . 192 The consensus-derived competencies are not intended to be an obesity curriculum. Rather, the expectation is that each of the groups involved in their development will adapt them to the needs of their specific profession; however, a limitation is that oncology was not represented among these groups.
191
A final issue is the need for providers to be sensitive to the issue of stigma and bias. The stigma associated with obesity may be secondary only to race. 193, 194 Because obesity is so highly stigmatized, providers who are uncomfortable with the topic and unaware of how to discuss it with their patients often add to this burden. 193 Consequently, patients with obesity may not receive the care they need. Therefore, the competencies include understanding terms that are acceptable to patients in discussions about weight and the need for joint decision making with respect to care.
Opportunities and Challenges Posed by New Technologies
Self-monitoring is a strong predictor of weight management success, 195 but engagement with self-tracking declines over time. 196 New technologies have improved adherence over traditional paper modes, and pairing feedback with tracking optimizes behavior change. 196 However, the challenges of maintaining self-monitoring of diet and PA remain. Daily weighing, via an internet-connected scale paired with text message feedback, has been found to promote clinically meaningful weight loss of 6% within 6 months in healthy populations. 197 These data suggest that self-monitoring strategies that are both discrete and simple achieve high engagement and desired clinical outcomes. However, mobile application (app) abandonment rates have been well documented in commercial and research settings. 198, 199 Such data indicate that multiple strategies (including Web, e-mail, interactive voice response, and text messaging) are needed to keep users connected to feedback or coaching and are necessary to complement self-monitoring strategies-strategies that may vary by population subgroup. Current research shows that feedback strategies that are real-time responsive (eg, app messages) are better positioned than those that are delayed (eg, weekly coaching calls), but there is a need to better understand the reasons why users disengage from technology. Moreover, while technology is currently used to address data collection, analytics, and integration with a goal of providing actionable feedback to users, the integration with health care professionals to provide health care decision support has yet to be made and is a needed leap.
Summary
The considerable body of research on weight management and PA interventions has documented myriad positive effects during and after cancer care. Despite the numerous challenges in delivering weight management and PA programs for cancer survivors, this is a time of unprecedented opportunity to include these programs as part of standard cancer and follow-up care. Several national trends and changes in health care are contributing to this opportunity while addressing some of the multilevel barriers to delivering these programs. At the level of the survivor and family, it is clear that engaged and activated patients participate more fully in their health care. Thus, efforts by clinical and public health groups have focused on patient activation and education about the importance of weight management and PA. Examples of this are patient education materials available on the websites of ASCO, the American Cancer Society (ACS), and the National Cancer Institute, as well as the Springboard Beyond Cancer mobile health tool (survivorship.cancer.gov) and SurvivorSHINE (survivorshine.org) websites, which help survivors change their lifestyle behaviors along with managing their ongoing symptoms and selfmanaging their health. The latter are examples of another ongoing trend discussed above: using technology to increase the feasibility of delivering interventions to survivors regardless of location. Technological solutions also may help reduce financial barriers to these programs for survivors who have limited economic resources. At the level of the health care professional and clinical practice, there are now multiple guidelines from the ACS, ACSM, ASCO, NCCN, and others delineating weight management and PA as part of overall cancer care and follow-up care. The work described above, to establish weight management competencies for clinicians, will help increase the ability of the clinical workforce to deliver appropriate care. In addition, health care professionals need safe and efficacious programs available for patient referral and time during the clinical encounter to discuss these issues and resources with patients and survivors. Interventions in community settings, such as LIVESTRONG at the YMCA, the availability of ACSM-certified Cancer Exercise Trainers in gyms across the country, and other programs for cancer survivors are helping to provide sources for appropriate referral. Finally, changes in American health care present an opportunity to integrate weight management and PA programs into cancer and follow-up care. The transition from fee-forservice to value-based payment models is also bringing attention to identifying interventions that are "good buys" (ie, that result in positive effects in multiple ways, in terms of patient outcomes and cost savings). The multiple positive effects of weight management and PA on overall health, well being, and QOL are prompting health care funders and decision makers look more seriously at these interventions.
Weight Management and PA Programs for Cancer Survivors: Models of Care
Successful incorporation of PA and weight management services into cancer survivorship care requires effective models of care delivery services. Because survivors come with a range of needs and preferences for services, oncology health care professionals need algorithms for assessing these factors to triage survivors and refer them to appropriate programs. Guidelines for providing smoking-cessation assistance in primary care settings use a schema that may prove useful in conceptualizing this process; the 5 As (Ask if a patient is smoking, Advise quitting, Assess patient motivation for making a quit attempt, Assist with counseling referral and pharmacotherapy, and Arrange follow-up within a week of quit date). 200 
Ask/Advise
Referral of cancer survivors to PA and weight management services starts with a conversation between the health care professional and their patient about these issues. A survey of 15,254 cancer survivors in the United Kingdom found that survivors who recalled a conversation with their care provider about exercise were 88% more likely to be physically active and to meet PA recommendations 201 ; however, only 31% of the respondents recalled such a conversation. In the US, discussion about PA is documented in only 35% of patientoncologist encounters. 202 Therefore, provider prompts may enhance discussions on this topic within the workflow and need to be considered in models of care delivery.
Assess
Cancer survivors have a range of needs and limitations regarding their symptoms, physical limitations, and comorbid health conditions that need to be considered. A process for assessing these conditions is necessary to determine optimal programs for weight loss or PA to ensure appropriate supervision and patient safety. At the same time, the cancer survivors' goals, preferences, and prior experience with PA and weight management need to be considered. The ACSM health screening guidelines, which take into account the patient's current activity level, signs and symptoms of disease, and desired intensity of exercise, are used to assess capacity for PA in the general population and may be useful to implement for cancer survivor populations. 203 Figure 1 provides an example of how survivor goals and preferences might interact in recommending an exercise program for a breast cancer survivor at risk for lymphedema.
Assist (or Refer)
Few clinical practices providing oncology/survivorship care are able to provide PA and weight management services and CA CANCER J CLIN 2017;00:00-00 VOLUME 00 _ NUMBER 00 _ MONTH 2017
often require referral to outside programs. There are growing numbers of programs available; some are cancer specific (eg, LIVESTRONG at the YMCA), but programs intended for the general population may also be appropriate (eg, Silver Sneakers). In addition, home-based or self-directed programs that rely on books and other print material, websites, mobile apps, and wearable devices (like pedometers and connected activity monitors and scales) can assist cancer survivors with PA and weight management. Cancer survivorspecific versions of such programs have shown efficacy in research studies but are not widely available outside of the research setting. Cancer survivors who have physical limitations or comorbid medical conditions may need to start with a clinic-based program, such as a cancer rehabilitation program or a medical weight-loss program. A challenge for health care professionals is knowing which programs are reliable and of high quality for cancer survivors. There is a need to develop and refine program standards and staff certification to optimize safety and effectiveness.
Connect
Even if effective programs are available, there often is a need to motivate cancer survivors to follow up on recommendations to access services. Research on smoking cessation shows that placing the onus of contact on the service provider (assuming that the patients' permission is obtained to share their contact information) can boost enrollment by 13-fold to 30-fold. 204, 205 A similar connection strategy could be used by an oncology clinic referring patients to programs like LIVESTRONG at the YMCA or cancer rehabilitation. Cancer survivors need access to a variety of safe and effective programs and clinical services to assist them with increasing PA and managing their weight. In addition, there also is a need to increase provider competencies; develop tools to assist providers; and build capacity in workflow and procedures that increase the likelihood that the patient-provider discussion about weight management and PA transpire, that referral to appropriate programs that are aligned with survivors' needs and preferences occurs, and that follow-through takes place.
Exemplar Programs
Over the past 2 decades, and with increasing recognition of the heightened needs of cancer survivors for supportive care to improve both emotional and physical health, several PA and weight management interventions have been developed and tested. Brief descriptions of some of these exemplars follow:
MOVE!
In 2006, the Veterans Health Administration implemented the MOVE! Weight Management Program for Veterans, 206 an evidence-based comprehensive lifestyle intervention available to veterans receiving care at all Veterans Health Administration medical centers. MOVE! assists veterans who are overweight or have obesity and an obesity-associated condition, such as cancer or CVD, to achieve clinically significant weight loss. 206 The program adheres to evidence-based recommendations from the Department of Veterans Affairs/Department of Defense Clinical Practice Guideline for Screening and Management of Overweight and Obesity, 207 which provides flexibility in addressing the unique needs of cancer survivors. The Department of Veterans Affairs/Department of Defense guideline recommendations include: yearly screening and documentation of overweight/obesity; pharmacotherapy and bariatric surgery as adjuncts to comprehensive lifestyle intervention; shared decision-making among providers and patients to support patient engagement based on individual values and preferences; and repeated assessment of response to treatment, with adjustments as needed to ensure clinically meaningful weight change. MOVE! and weight management care are embedded within the health care system while also supporting care coordination across primary and specialty care settings (including oncology) and inpatient and outpatient care.
LIVESTRONG at the YMCA Over the past decade the YMCA, which consists of a national resource center (YMCA of the USA, or Y-USA) and over 2700 local YMCAs, has partnered with many public health and health care stakeholders to transform its network to better serve the health of the nation. Local YMCAs are trained to build their capacity and to develop competencies needed to become a strong partner. Thereafter, they are licensed to deliver standardized programs and services for those with special health needs (eg, the YMCA's DPP for people with prediabetes, Healthy Weight and Your Child for families with children who are challenged by obesity, etc). To address the challenges faced by cancer survivors, Y-USA partnered with the LIVESTRONG Foundation to develop and scale a 12-week PA program. The program model was nested within a 6-month organizational change process modeled after the Institute for Health Care Improvement's "Plan, Do, Study, Act." Local YMCAs that have an interest in serving cancer survivors within their communities are encouraged to submit a readiness assessment to Y-USA. The LIVESTRONG Foundation, the local YMCA leadership, and, more recently, the Centers for Disease Control and Prevention have supported YMCAs that demonstrate the highest levels of commitment to go through the organizational change process and become trained and authorized to deliver the LIVE-STRONG at the YMCA program. Through the organizational change process, YMCA staff build competencies, such as those related to understanding cancer survivors' needs, providing welcoming environments, and developing partnerships with local cancer centers and oncology health care professionals. The PAL intervention was originally implemented in select YMCAs in which fitness staff received training (including preintervention safety evaluations) and ongoing support from PAL investigators. Because of high staff turnover at the YMCAs, concern about implementing safety evaluations, and an unwillingness of participants to continue to pay for YMCA memberships, this program led to the creation of "Strength After Breast Cancer"-a dissemination and implementation study to translate PAL into the setting of outpatient rehabilitation. 221 As noted in other effective interventions, the "Strength After Breast Cancer" intervention optimally begins with a referral by the oncology/primary care provider to the outpatient rehabilitation clinic, which then contacts the patient. Clinic staff implement a safety evaluation, then deliver an educational session on lymphedema, as well as 4 sessions of weight-lifting instruction, before release to a home-based program. Favorable comparison of the efficacy of this revised program with the original PAL trial led to an online continuing-education course that targets outpatient rehabilitation specialists (klosetraining.com/course/online/strengthabc). 221 Over 400 outpatient rehabilitation clinicians have completed the course, and no difficulties have been reported in obtaining third-party payer reimbursement. , with a wide range of cancers. The retention (program completion) rate is 57%. Among the first 200 program completers, significant (P < .05) and clinically meaningful improvements have been seen in all secondary, patient-reported outcomes. This collaborative undertaking provides an opportunity for national dissemination of an evidence-based intervention to support healthy living among cancer survivors. Rigorous evaluation of service-level and patient-reported outcomes will provide the practicebased evidence needed to achieve sustained support.
Healthy Living after Cancer
Summary
MOVE!, Strength After Breast Cancer, LIVESTRONG at the Y, and HLaC all serve as model programs that effectively address the PA and weight management needs of cancer survivors. These programs, and many others like them, have established feasibility, safety, and efficacy. Although they are successful, common challenges, such as referral, training, triage, support, and reimbursement, remain as barriers.
Insurance Coverage of Weight Management and PA in Cancer Care
Obesity presents unique challenges in patients with cancer; however, because of the high prevalence of obesity within the United States and its association with a constellation of chronic diseases, 222 most payers consider it a general concern across all of their health plan membership.
Although evidence of what works in the treatment of obesity is growing, 54, 223, 224 the services that are covered and how the coverage is implemented in health benefit plans remain highly variable. Private and governmental payers of health insurance/benefit plans consider multiple factors as they decide what to cover and how to implement coverage. While many consumers and health care professionals assume that coverage decisions are based solely on cost, payers generally consider several factors in coverage decisions, including consumer/employer demand for a service, evidence for effectiveness and efficiency of the service, the ability to administer the benefit consistently and fairly, the presence of state/federal governmental mandates for a service, and how the benefit will affect the marketability/adverse selection of a health plan.
In its role as a fiduciary agent for its members, and for taxpayers in the case of the Centers for Medicare and Medicaid Services (CMS), insurers are faced with balancing their fiscal responsibilities with the mission and values of their organizations. An insurer first determines whether a service is effective, and then assesses the impact of that service on the overall cost of care for the members using that service. For example, coverage of the previously mentioned Y-USA DPP was based on relatively short-term data from a CMS Innovation Center demonstration project that indicated modest weight loss and significant savings in total costs of care. However, because the program was projected to reduce premature mortality, actuarial evaluation suggested that the program could ultimately lead to higher costs for Medicare patients who had care needs for a longer period of time. In response, CMS determined that longer life would not be considered as a cost (ie, care costs over a longer life span were zeroed-out). As a result, CMS announced that, in 2018, Medicare would begin reimbursing all DPP programs that meet CDC requirements. 225 Interestingly, as value-based payment systems become more prevalent for both government and private payers, issues historically considered within the insurer's purview will shift to health care providers who share the financial risks (eg, next-generation ACOs). 226 These payment models provide payment based on a defined population of consumers and include incentives and potential penalties for both quality and cost metrics. Private payers, including multistate Anthem Blue Cross and Blue Shield and most national health plans, have developed similar value-based payment models. The expectation is that ACOs, or groups of physicians, hospitals, and other health professionals who come together voluntarily to provide coordinated highquality care, will provide services that improve the overall health and well being for a defined set of patients, including both clinical and community services for the prevention and treatment of obesity. Although ACOs currently account for approximately 10% of the private health insurance market, insurers such as Anthem indicate that up to 60% of their fully insured membership may be covered under value-based payment models. The US Department of Health and Human Services has set a goal of tying 90% of all Medicare fee-for-service payments to quality or value metrics by 2018. 227 Value-based metrics, however, are evolving and incomplete. The National Quality Forum has only endorsed 4 screening metrics related to obesity and has yet to reach consensus on any outcome measures, 228 but promising developments have transpired with Medicare coverage of the DPP, which includes an outcomes-based payment tied to both short-term and long-term patient outcomes. The Bipartisan Policy Center has convened both commercial and government payers to discuss coverage for services related to obesity, including an effort to develop a shared-benefit design. Their discussions have focused on benchmarks of efficacy and cost effectiveness, in addition to issues related to member retention, return on investment, community partnerships, senior leadership support, and data tracking. Thus health professionals interested in working with payers to improve coverage for obesity-related services need to understand not only the needs of their patients but also the context in which payers make their coverage determinations.
Advancing Progress in Tertiary Prevention: Stakeholder Insights and Recommendations
As cancer treatment advances and survivors live significantly longer, enhancing health and QOL for cancer survivors has become a major public health goal-one that also has widespread implications for the financial well being of survivors and families and of the health care system. Evidence continues to accumulate strongly suggesting that weight management and PA can improve the management of cancer, comorbid conditions, and QOL. However, there are 3 urgent challenges that must be overcome to connect cancer survivors with interventions that can ideally help them.
The first challenge is identifying the optimal type of intervention for a given survivor (eg, specific tumor type, cultural factors, comorbidities, functional status) and a specific goal (eg, fatigue management or decreasing risk of recurrence). This involves research to test varied types of interventions and to capture multiple types of patient data (tumor subtypes, clinical laboratory values, patient-reported symptom data) in multiple settings (identifying who needs medically supervised programs vs who benefits from community programs vs home-based interventions).
The second challenge is identifying how to deliver evidence-based interventions to support weight management and PA, not only in medical settings but also in the community or through the use of technology. Effective examples of model programs exist (eg, MOVE!, Strength After Breast Cancer, LIVESTRONG, and HLaC). Research is needed to continue to test clinic-based, community-based, and technology-delivered interventions and to identify how to facilitate referrals from oncologists and other health care professionals to these interventions. Educating health care providers about the importance of these interventions is a valuable but insufficient step. Future efforts need to address how to integrate weight management and PA interventions into standard cancer care.
The third challenge is accumulating the right data about weight management and PA programs to inform health care payer decisions to cover these interventions. Reimbursement by insurers will help make these interventions more affordable for survivors and drive widespread availability of these services. Part of this evidence will come from ongoing trials that will provide evidence regarding the benefits of postdiagnosis weight management and PA on recurrence and survival. However, even if these interventions do not specifically affect recurrence, coverage decisions may be made based on comorbidity management or effects on downstream health care utilization. Future research needs to test the cost effectiveness of these interventions on these important outcomes to inform health care coverage decisions.
The key to our success in implementing weight management and PA programs will be to bridge the silos of expertise, as represented in the NCPF workshop in 2017 in cancer biology, epidemiology, survivorship, nutrition, PA, weight management, and economics, as well as health care systems (eg, ACOs, payers, hospitals, oncology practices), care providers (eg, oncologists, primary care providers, allied health professionals, cancer rehabilitation, behavioral medicine) and the community (eg, advocacy organizations, YMCAs). The efforts to implement effective programs will need to address individual, provider/workforce, and systemic barriers, which include barriers specific to cancer survivors (symptoms and treatment side effects), as well as individual and cultural differences. The challenge is great. The opportunities and benefits of collaboration across disciplines and key stakeholders have significant potential to enhance outcomes for the growing number of cancer survivors in the United States and beyond. 
